Biomanufacturing technology roadmap: 5. Modular and mobile

Modular and Mobile changing the way we construct facilities

Biopharmaceuticals are currently produced in fixed facilities that require significant upfront, at-risk capital investment.

Modular and Mobile concepts offer an opportunity to shift this paradigm away from these large, fixed assets to networks of smaller, standardized manufacturing facilities that can be built in less than half the time and in a way that defers cost until there is greater certainty about market demand and the probability of success. Amongst the other benefits of this approach to facility design is that this standardization of the manufacturing platform provides the opportunity to accelerate the delivery of therapies to the market whilst the responsiveness of the supply chains can be improved and the regulatory review for new products and for adding additional capacity can be simplified.

Attached Files

Please enter your name and E-mail below to gain access to this download.
This field is for validation purposes and should be left unchanged.

  • Version
  • Download 1104
  • File Size 0.00 KB
  • File Count 1
  • Create Date 9th May 2017
  • DOI
  • Last Updated